G

Greenrise Global Brands Inc
CNSX:XCX

Watchlist Manager
Greenrise Global Brands Inc
CNSX:XCX
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: CA$258.3k

Greenrise Global Brands Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Greenrise Global Brands Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Greenrise Global Brands Inc
CNSX:XCX
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HLS Therapeutics Inc
TSX:HLS
Revenue
$55.5m
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
M
Manitex Capital Inc
XTSX:MNX
Revenue
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Greenrise Global Brands Inc
Glance View

Market Cap
258.3k CAD
Industry
Health Care

Greenrise Global Brands, Inc. engages in the supply of medical cannabis to pharmacies through its subsidiaries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-03-16. The firm is engaged in the business of CBD wellness, medical and emerging recreational cannabis operations in Germany. Its brands include Herbify and CANAVEX. The company supplies medical cannabis products to pharmacies across Germany. The Herbify brand is a CBD-based cosmetics and wellness product which is sold in retail and online. The CANAVEX brand contains all natural components of the hemp plant (terpenes) as well as a standardized proportion of 5% CBD. CANAVEX is a therapeutic CBD cosmetic brand sold in German pharmacies.

XCX Intrinsic Value
0.018 CAD
Undervaluation 73%
Intrinsic Value
Price CA$0.005
G

See Also

What is Greenrise Global Brands Inc's Revenue?
Revenue
0 EUR

Based on the financial report for Sep 30, 2025, Greenrise Global Brands Inc's Revenue amounts to 0 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett